BRAF and thyroid gland carcinoma: These data, taken together, suggest that STAG2 inactivation reduces protein stability of c-Myc via the ERK/AKT/GSK3β feedback axis, thereby reprograming glutamine metabolism of BRAF-mutant thyroid cancer cells.